80.95

0.91% 0.73

After Hours: 80.90 -0.05 -0.06%

Medtronic Plc (MDT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Medtronic Plc stock is traded at $80.95, with a volume of 4.43M. It is up +0.91% in the last 24 hours and down -5.55% over the past month. One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Previous Close:

$80.22

Open:

$80.5

24h Volume:

4.43M

Relative Volume:

0.87

Market Cap:

$103.80B

Revenue:

$33.00B

Net Income/Loss:

$4.29B

P/E Ratio:

24.76

EPS:

3.27

Net Cash Flow:

$5.50B

1W Performance:

+0.26%

1M Performance:

-5.55%

6M Performance:

+4.90%

1Y Performance:

-2.70%

1-Day Range:

$79.98

$81.00

1-Week Range:

$79.29

$81.00

52-Week Range:

$75.96

$92.68

Medtronic Plc Stock (MDT) Company Profile

Name

Medtronic Plc

Sector

Healthcare (1174)

Industry

Medical Devices (149)

Phone

01135314381700

Address

BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY

Employee

95,000

Twitter

@Medtronic

Next Earnings Date

2024-11-19

Latest SEC Filings

MDT's Discussions on Twitter

Compare MDT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDT Medtronic Plc	80.95	103.80B	33.00B	4.29B	5.50B	3.27
ABT Abbott Laboratories	113.83	197.43B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	361.52	137.82B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	90.69	133.66B	15.91B	1.79B	1.89B	1.21
EW Edwards Lifesciences Corp	73.91	43.59B	6.60B	4.16B	490.10M	6.93

Medtronic Plc Stock (MDT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-10-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Aug-21-24	Reiterated	Oppenheimer	Perform
Aug-15-24	Upgrade	UBS	Sell → Neutral
Aug-14-24	Downgrade	Stifel	Buy → Hold
May-30-24	Initiated	Goldman	Sell
Jul-19-23	Initiated	Robert W. Baird	Neutral
Jun-30-23	Initiated	CL King	Buy
May-30-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Apr-24-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Mar-29-23	Downgrade	UBS	Buy → Sell
Jan-09-23	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-23-22	Downgrade	Citigroup	Buy → Neutral
Nov-23-22	Downgrade	Oppenheimer	Outperform → Perform
Nov-16-22	Downgrade	Deutsche Bank	Buy → Hold
Oct-18-22	Initiated	Barclays	Equal Weight
Oct-13-22	Initiated	Mizuho	Buy
Oct-12-22	Initiated	Jefferies	Hold
Aug-24-22	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-06-22	Initiated	Wolfe Research	Underperform
Jun-01-22	Downgrade	Atlantic Equities	Overweight → Neutral
May-27-22	Downgrade	Needham	Buy → Hold
Apr-13-22	Downgrade	Truist	Buy → Hold
Mar-02-22	Resumed	BofA Securities	Buy
Jan-10-22	Downgrade	BTIG Research	Buy → Neutral
Jan-07-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-04-22	Downgrade	Piper Sandler	Overweight → Neutral
Dec-17-21	Downgrade	JP Morgan	Overweight → Neutral
Dec-16-21	Downgrade	Wells Fargo	Overweight → Equal Weight
Dec-10-21	Initiated	RBC Capital Mkts	Outperform
Jun-10-21	Resumed	Cowen	Outperform
May-25-21	Initiated	Barclays	Equal Weight
Apr-15-21	Initiated	Atlantic Equities	Overweight
Dec-15-20	Upgrade	Goldman	Sell → Neutral
Dec-15-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-08-20	Upgrade	Bernstein	Mkt Perform → Outperform
Oct-08-20	Upgrade	Stifel	Hold → Buy
Sep-11-20	Initiated	Wolfe Research	Peer Perform
May-14-20	Downgrade	DZ Bank	Buy → Hold
Mar-30-20	Downgrade	Needham	Strong Buy → Buy
Mar-25-20	Upgrade	DZ Bank	Hold → Buy
Mar-05-20	Initiated	Citigroup	Buy
Feb-13-20	Initiated	Goldman	Sell
Jan-08-20	Initiated	SunTrust	Buy
Jan-02-20	Upgrade	Guggenheim	Neutral → Buy
Jun-05-19	Upgrade	Wells Fargo	Market Perform → Outperform
Feb-04-19	Reiterated	Needham	Strong Buy
Jan-03-19	Initiated	Deutsche Bank	Buy
Jan-02-19	Downgrade	Citigroup	Buy → Neutral
Dec-19-18	Upgrade	JP Morgan	Neutral → Overweight
Nov-28-18	Initiated	UBS	Buy
Oct-16-18	Initiated	Barclays	Overweight
Aug-27-18	Reiterated	Argus	Buy